Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06187415
Other study ID # HarmReductionAPPService
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date December 31, 2024

Study information

Verified date March 2024
Source National Cheng Kung University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is examining the usability and effectiveness of an innovative mobile app that integrates harm reduction strategies into the existing pre-exposure prophylaxis (PrEP) intake and adherence app, with an overarching goal to reduce the potentially negative consequences of problematics chemsex behavior for individuals and communities.


Description:

The practice of sexualized drug use is historical and has been noted across a diversity of genders and people of various sexual orientations. The term "chemsex" has been used to specifically describe the use of psychoactive substances in sexualized settings among gay, bisexual, and other men who have sex with men (GBMSM), particularly stimulants like methamphetamine and mephedrone, or other drugs like γ-hydroxybutyrate (GHB), γ-butyrolactone (GBL). Chemsex among GBMSM has coincided with the emergence of sexual-networking mobile apps, creating new opportunities for finding new partners with the intention to engage in chemsex. Harm reduction strategies for GBMSM engaging in chemsex are needed because the use of these drugs can have negative consequences for the physical and mental health of the people who use them. One of the main risks associated with chemsex is the possibility of overdose. In addition to the risk of overdose, chemsex may also increase the risk of sexually transmitted infections (STIs) and HIV transmission due to the higher possibility to engage in risky sexual behaviors. Seeking help can be difficult for GBMSM who engage in chemsex due to stigma, making the harm reduction approach equally important as clinical treatment or intervention that emphasized an abstinence approach. Harm reduction strategies recognize that drug use is a complex issue and that it is not always possible or desirable for people to stop using drugs completely. Instead, harm reduction approaches aim to reduce the harm that can result from drug use and to support people in making healthier choices. Considering also that mobile applications are another way to provide help to hard to reach population, this study aims to develop an innovative mobile app that integrates harm reduction strategies into the existing pre-exposure prophylaxis (PrEP) intake and adherence app. PrEP is a medication that can be taken daily to reduce the risk of HIV transmission. The aim of including PrEP adherence in the self-help harm reduction strategy is to ensure that participants have access to and are using an effective HIV prevention method. Behavior regulation strategies such as providing education about the risks of drug use, overdose prevention and management, and HIV prevention through correct PrEP intake, can be integrated into a mobile app that aims to minimize the negative consequences of drug use and reduce the risks associated with it, with an overarching goal to reduce the potentially negative consequences of problematics chemsex behavior for individuals and communities.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 120
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - individuals need to have a history of drug use (ecstasy, ketamine, crystal methamphetamine, mephedrone, and/or GHB/GBL)in a sexualized context in the previous year - can read and understand chinese, - willing to communicate with the research team through the mobile messenger app Line. Exclusion criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mobile app to reduce harm of chemsex
Access to the mobile app which includes PrEP diary, demistification of chemsex urban legends, information on the location of needle and syringe services program, and alert sending to emergency contact.

Locations

Country Name City State
Taiwan NationalCKU Tainan

Sponsors (2)

Lead Sponsor Collaborator
National Cheng Kung University Healing, Empowerment, Recovery of Chemsex (HERO) integrated care clinic

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Harm reduction behavior a questionnaire will assess the change in chemsex harm reduction behavior every three months 3 months
Primary Self-efficacy for sexual safety scores on the self-efficacy for the sexual safety scale will be measured every 3 months. The total score ranges from 7 to 35. A higher score will indicate a higher level of self-efficacy for safe sex 3 months
Primary Self-reported negative chemsex experiences a questionnaire will be used to assess the change in the magnitude of negative chemsex experiences 3 months
Secondary Depression scores on the Patient Health Questionnaire (PHQ-9) will be assessed every three months. The scores ranges from 0 to 27. A cutoff score of 10 indicates major depression 3 months
Secondary Sleep quality Scores on the Single-Item Sleep Quality Scale will be measured every three months. The scores ranges from 0 to 10 where in 0 means terrible sleep quality, 1 to 3 means poor, 4 to 6 means fair, 7 to 9 means good and 10 means excellent. 3 months
Secondary Suicide Scores on the Suicide Behavior Questionnaire-Revised (SBQ-R) item 1 will be measured every three months. The cut off score that will be used in identifying individuals with established suicide status is 2 1 month
Secondary Sexual satisfaction Scores on the satisfaction on sex life scale-revised measured every three months. Higher score means better sexual satisfaction 3 months
Secondary Usability and acceptability of the app Scores on the mHealth App Usability questionnaire measured at the first month of follow up. Scores range from 18 to 126. The questionnaire score is that total score of each item divided by the number of items. The closer the mean value is to 1, the higher the app's usability will be. 1 month
Secondary Feasibility of the app measured by collecting data from app analytics one month after administering the baseline questionnaire 1 month
Secondary Drug dependence Scores on the severity of dependence scale measured every three months of follow up. Total score ranges from 0 to 15. A higher total score indicates a higher level of dependence. 3 months
Secondary Goal changes A questionnaire will be used to provide a descriptive account of harm reduction goal changes. It will be assessed every three months 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05463341 - Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties N/A
Recruiting NCT02425657 - Fast Track Module Based Colonoscopy Training Programme for Surgical Trainees at North Jutland Surgical Departments
Completed NCT04253158 - Implementation of a Web-based Alcohol and Other Drug Prevention Intervention for Collegiate Student-athletes N/A
Active, not recruiting NCT04700930 - CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia N/A
Recruiting NCT05994703 - Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine Phase 2
Completed NCT04210180 - Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction Phase 2/Phase 3
Recruiting NCT06115746 - A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students N/A
Recruiting NCT05493475 - Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants N/A
Terminated NCT03675503 - Reducing Hospital Falls by Empowering Nurses to Provide Ambulatory Aids N/A
Completed NCT01838473 - In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users Phase 1
Completed NCT01369693 - In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus Phase 1
Completed NCT01249339 - In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus Phase 1
Completed NCT04250727 - Switching to Potential Reduced Exposure Products in Adult Smokers N/A
Completed NCT04650269 - Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program Phase 4
Completed NCT04268173 - Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3 Phase 3
Not yet recruiting NCT04351958 - An Augmented Reality Videogame for Alcohol Use Prevention and Harm Reduction in Teens N/A
Active, not recruiting NCT05404815 - Exposure to Plasticisers in the Neonatal Intensive Care Unit
Not yet recruiting NCT06429436 - Vending Machine Naloxone Distribution for Your Community (VENDY) Phase 4
Not yet recruiting NCT06372899 - Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers N/A
Recruiting NCT05516069 - Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction. N/A